JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1701
Donaldson
DCI
$10.2B
| $22.8M | ﹤0.01% |
349,651
+64,461
| +23% | +$3.93M |
2013 Q2
42 quarters
|
|
1702
Dorian LPG
LPG
$2.42B
| $22.8M | ﹤0.01% |
520,421
+34,369
| +7% | +$1.28M |
2016 Q4
28 quarters
|
|
1703
Trex
TREX
$4.43B
| $22.8M | ﹤0.01% |
275,622
-6,115
| -2% | -$406K |
2013 Q2
42 quarters
|
|
|
EQC
1704
DELISTED
Equity Commonwealth
EQC
| $22.8M | ﹤0.01% |
1,187,573
+188,204
| +19% | +$3.56M |
2013 Q2
42 quarters
|
|
1705
Vanguard Energy ETF
VDE
$10.6B
| $22.7M | ﹤0.01% |
193,844
+78,469
| +68% | +$9.41M |
2015 Q3
33 quarters
|
|
1706
Tenaris
TS
$28.1B
| $22.7M | ﹤0.01% |
653,799
+74,874
| +13% | +$2.51M |
2015 Q3
33 quarters
|
|
|
MFA
1707
MFA Financial
MFA
$782M
| $22.7M | ﹤0.01% |
2,013,201
-863,900
| -30% | -$8.73M |
2013 Q2
42 quarters
|
|
1708
Invesco FTSE RAFI US 1000 ETF
PRF
$9.8B
| $22.7M | ﹤0.01% |
643,892
+349,181
| +118% | +$11.4M |
2018 Q3
21 quarters
|
|
1709
Liberty Latin America Class C
LILAK
$1.63B
| $22.7M | ﹤0.01% |
3,384,097
+343,007
| +11% | +$2.22M |
2015 Q3
33 quarters
|
|
1710
PUT
Monster Beverage
MNST
$82.6B
| $22.6M | ﹤0.01% |
785,000
+37,800
| +5% | +$1.01M |
2021 Q3
9 quarters
|
|
1711
TriNet
TNET
$2.98B
| $22.6M | ﹤0.01% |
189,909
-9,994
| -5% | -$1.14M |
2014 Q2
38 quarters
|
|
1712
Paylocity
PCTY
$7.78B
| $22.6M | ﹤0.01% |
136,908
+10,679
| +8% | +$1.8M |
2015 Q4
32 quarters
|
|
1713
MGE Energy Inc
MGEE
$2.65B
| $22.6M | ﹤0.01% |
312,048
+33,833
| +12% | +$2.45M |
2013 Q2
42 quarters
|
|
1714
iShares US Energy ETF
IYE
$1.68B
| $22.6M | ﹤0.01% |
511,142
+399,919
| +360% | +$18M |
2013 Q2
42 quarters
|
|
1715
iShares MSCI Indonesia ETF
EIDO
$420M
| $22.5M | ﹤0.01% |
1,009,518
+133,080
| +15% | +$2.86M |
2022 Q1
7 quarters
|
|
1716
iShares Latin America 40 ETF
ILF
$3.8B
| $22.5M | ﹤0.01% |
775,061
-87,651
| -10% | -$2.35M |
2013 Q2
42 quarters
|
|
1717
MSC Industrial Direct
MSM
$7.18B
| $22.5M | ﹤0.01% |
222,383
+42,570
| +24% | +$4.21M |
2013 Q2
42 quarters
|
|
1718
Exponent
EXPO
$3.32B
| $22.5M | ﹤0.01% |
255,722
+76,855
| +43% | +$6.3M |
2013 Q2
42 quarters
|
|
1719
City Holding Co
CHCO
$1.99B
| $22.5M | ﹤0.01% |
203,691
-4,296
| -2% | -$420K |
2013 Q2
42 quarters
|
|
|
SWTX
1720
DELISTED
SpringWorks Therapeutics
SWTX
| $22.5M | ﹤0.01% |
615,222
+48,298
| +9% | +$1.26M |
2019 Q4
16 quarters
|
|
1721
Green Plains
GPRE
$1.05B
| $22.4M | ﹤0.01% |
890,062
-50,693
| -5% | -$1.34M |
2013 Q2
42 quarters
|
|
1722
Rocket Pharmaceuticals
RCKT
$284M
| $22.4M | ﹤0.01% |
748,340
-14,545
| -2% | -$321K |
2018 Q2
22 quarters
|
|
1723
PUT
CVS Health
CVS
$109B
| $22.4M | ﹤0.01% |
283,500
+171,100
| +152% | +$12.2M |
2021 Q2
10 quarters
|
|
1724
Travel + Leisure Co
TNL
$3.86B
| $22.4M | ﹤0.01% |
571,926
-323,684
| -36% | -$11.7M |
2013 Q2
42 quarters
|
|
1725
Interparfums
IPAR
$3.58B
| $22.3M | ﹤0.01% |
155,083
-15,073
| -9% | -$1.97M |
2013 Q2
42 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.